Suppr超能文献

用[125I]CGP 42112对血管紧张素II AT2受体进行定量放射自显影。

Quantitative autoradiography of angiotensin II AT2 receptors with [125I]CGP 42112.

作者信息

Heemskerk F M, Saavedra J M

机构信息

Section on Pharmacology, National Institute of Mental Health, Bethesda, MD 20982, USA.

出版信息

Brain Res. 1995 Apr 17;677(1):29-38. doi: 10.1016/0006-8993(95)00092-5.

Abstract

Most radiolabeled ligands for angiotensin II (Ang II) receptors do not discriminate between the AT1 and AT2 receptor subtypes, which must be distinguished by displacement with selective AT1 or AT2 ligands. We compared [125I]CGP 42112 with the non-selective agonist [125I]Sar1 Angiotensin II. We studied the inferior olive, medial geniculate nucleus and the adrenal medulla, areas rich in AT2 receptors, using both ligands with quantitative autoradiography and membrane binding techniques. [125I]CGP 42112 bound with high affinity (Kd = 0.07-0.3 nM, depending on the area studied). [125I]CGP 42112 binding was selective for AT2 receptors, as determined by lack of competition with the AT1 ligand losartan, and competition by the AT2 ligands PD 123177 and unlabeled CGP 42112 and the non-selective peptides Ang II and angiotensin III (Ang III). Using [125I]CGP 42112 binding, we found the same order of potency: CGP 42112 > Ang II = Ang III > PD 123177 using both quantitative autoradiography or membrane binding methods. Our results demonstrate that [125I]CGP 42112 is the most selective, highest affinity ligand available for AT2 receptors. Because of these characteristics, and low non-specific binding, quantitative autoradiography with [125I]CGP 42112 is the method of choice to selectively characterize AT2 receptors, especially in tissues like the brain, with a highly heterogeneous distribution of receptor subtypes.

摘要

大多数用于血管紧张素II(Ang II)受体的放射性标记配体无法区分AT1和AT2受体亚型,必须通过用选择性AT1或AT2配体进行置换来加以区分。我们将[125I]CGP 42112与非选择性激动剂[125I]Sar1血管紧张素II进行了比较。我们使用这两种配体,通过定量放射自显影和膜结合技术,研究了富含AT2受体的下橄榄核、内侧膝状体核和肾上腺髓质。[125I]CGP 42112以高亲和力结合(Kd = 0.07 - 0.3 nM,取决于所研究的区域)。[125I]CGP 42112的结合对AT2受体具有选择性,这是通过与AT1配体氯沙坦缺乏竞争以及与AT2配体PD 123177、未标记的CGP 42112以及非选择性肽血管紧张素II和血管紧张素III(Ang III)存在竞争来确定的。使用[125I]CGP 42112结合,我们通过定量放射自显影或膜结合方法发现了相同的效价顺序:CGP 42112 > 血管紧张素II = 血管紧张素III > PD 123177。我们的结果表明,[125I]CGP 42112是可用于AT2受体的最具选择性、最高亲和力的配体。由于这些特性以及低非特异性结合,用[125I]CGP 42112进行定量放射自显影是选择性表征AT2受体的首选方法,尤其是在受体亚型分布高度不均一的脑组织等组织中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验